Group One Trading
ANIP icon

Group One Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Group One Trading’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$119K – 7217
2024
Q3 		$119K Buy
+2,000
New +$122K ﹤0.01% 4025
2024
Q2 		– Sell
-25,000
Closed -$1.73M – 6664
2024
Q1 		$1.73M Buy
+25,000
New +$1.51M 0.01% 1606
2023
Q4 		– Sell
-2,000
Closed -$116K – 7333
2023
Q3 		$116K Hold
2,000
– – ﹤0.01% 4319
2023
Q2 		$108K Hold
2,000
– – ﹤0.01% 4545
2023
Q1 		$79.4K Buy
+2,000
New +$84.3K ﹤0.01% 4499
2022
Q3 		– Sell
-500
Closed -$15K – 7501
2022
Q2 		$15K Buy
500
+300
+150% +$8.65K ﹤0.01% 6491
2022
Q1 		$6K Hold
200
– – ﹤0.01% 7354
2021
Q4 		$9K Buy
+200
New +$8.59K ﹤0.01% 7383
2020
Q1 		– Sell
-100
Closed -$6K – 5203
2019
Q4 		$6K Sell
100
-5,000
-98% -$331K ﹤0.01% 4706
2019
Q3 		$372K Buy
5,100
+4,900
+2,450% +$367K ﹤0.01% 2585
2019
Q2 		$16K Buy
+200
New +$14.2K ﹤0.01% 4255
2018
Q2 		– Sell
-2,500
Closed -$146K – 5056
2018
Q1 		$146K Sell
2,500
-2,200
-47% -$140K ﹤0.01% 3007
2017
Q4 		$303K Buy
4,700
+3,700
+370% +$230K ﹤0.01% 2638
2017
Q3 		$52K Buy
1,000
+400
+67% +$19.1K ﹤0.01% 3606
2017
Q2 		$28K Sell
600
-3,000
-83% -$145K ﹤0.01% 3809
2017
Q1 		$178K Buy
3,600
+2,400
+200% +$135K ﹤0.01% 2594
2016
Q4 		$73K Sell
1,200
-1,100
-48% -$67.3K ﹤0.01% 3022
2016
Q3 		$153K Sell
2,300
-3,000
-57% -$188K ﹤0.01% 2651
2016
Q2 		$296K Sell
5,300
-800
-13% -$38.9K ﹤0.01% 2138
2016
Q1 		$205K Buy
6,100
+5,100
+510% +$173K ﹤0.01% 2298
2015
Q4 		$45K Buy
+1,000
New +$43K ﹤0.01% 3468
2015
Q3 		– Sell
-100
Closed -$6K – 4829
2015
Q2 		$6K Buy
+100
New +$5.95K ﹤0.01% 4433
2013
Q4 		– Sell
-100
Closed -$1K – 5187
2013
Q3 		$1K Buy
+100
New +$721 ﹤0.01% 5020

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Group One Trading's ANIP Position: Q1 2026 in Review

Group One Trading reduced its ANI Pharmaceuticals (ANIP) stake by 50% in Q1 2026, selling an estimated $7.8K and leaving 100 shares worth $7.69K. The position accounts for ﹤0.01% of the portfolio, ranked #6509.

Group One Trading first reported a position in ANIP in Q2 2013 and has held it in 13 quarters since. The position peaked at $292K in Q3 2019. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Group One Trading held 100 shares of ANI Pharmaceuticals worth $7.69K as of Q1 2026.
  • Group One Trading sold 100 ANI Pharmaceuticals shares in Q1 2026, an estimated $7.8K.
  • ANI Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6509 holding.
  • Group One Trading first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
  • Group One Trading's ANI Pharmaceuticals position peaked at $292K in Q3 2019.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.